Vaccinia Capping System, New England BiolabsSupplier: New England Biolabs (NEB)
101641-574EA 143.5 USD InStockCA101641-574 101641-574
Vaccinia Capping System, New England Biolabs
Based on the Vaccinia virus Capping Enzyme, the Vaccinia Capping System provides the necessary components to add 7-methylguanylate cap structures (Cap 0) to the 5´end of RNA.
In eukaryotes, these terminal cap structures are involved in stabilization, transport, and translation of mRNAs. Enzymatic production of capped RNA is an easy way to improve the stability and translational competence of RNA used for in vitro translation, transfection, and microinjection. Alternatively, use of labeled GTP in a reaction provides a convenient way to label any RNA containing a 5´ terminal triphosphate. This single enzyme is composed of two subunits (D1 and D12) and has three enzymatic activities (RNA triphosphatase and guanylyltransferase by the D1 subunit and guanine methyltransferase by the D12 subunit); all necessary for addition of a complete Cap 0 structure, m7Gppp5´N. In vitro transcripts can be capped in less than one hour in the presence of the capping enzyme, reaction buffer, GTP, and the methyl donor, SAM. Capping is nearly 100% efficient and all capped structures are added in the proper orientation, unlike co-transcriptional addition of some cap analogs.